The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from Business Wire

Rigrodsky & Long, P.A. Announces Investigation Of Onyx Pharmaceuticals, Inc. Buyout

Tuesday, August 27, 2013

Rigrodsky & Long, P.A. Announces Investigation Of Onyx Pharmaceuticals, Inc. Buyout

18:09 EDT Tuesday, August 27, 2013

WILMINGTON, Del. (Business Wire) -- Rigrodsky & Long, P.A.:

  • Do you own shares of Onyx Pharmaceuticals, Inc. (NASDAQ GS: ONXX )?
  • Did you purchase any of your shares prior to August 25, 2013?
  • Do you think the proposed buyout price is too low?
  • Do you want to discuss your rights?

Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Onyx Pharmaceuticals, Inc. (“Onyx” or the “Company”) (NASDAQ GS: ONXX) regarding possible breaches of fiduciary duties and other violations of law related to the Company's entry into an agreement to be acquired by Amgen Inc. (“Amgen”) (NASDAQ GS: AMGN) in a transaction valued at approximately $10.4 billion.

Click here to learn more: http://www.rigrodskylong.com/investigations/onyx-pharmaceuticals-inc-onxx.

Under the terms of the agreement, public shareholders of Onyx will receive $125.00 per share in cash for each share of Onyx they own.

The investigation concerns whether Onyx's board of directors failed to adequately shop the Company and obtain the best possible value for Onyx's shareholders before entering into an agreement with Amgen. According to Yahoo! Finance, at least one analyst has set a price target for Onyx stock at $160.00 per share.

If you own the common stock of Onyx and purchased your shares before August 25, 2013, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brian Long or Shaye Fuchs at Rigrodsky & Long, P.A., 825 East Gate Boulevard, Suite 300, Garden City, New York 11530, by telephone at (888) 969-4242; by e-mail to info@rl-legal.com, or at: http://www.rigrodskylong.com/investigations/onyx-pharmaceuticals-inc-onxx.

Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly prosecutes securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, on behalf of shareholders in states and federal courts throughout the United States.

Attorney advertising. Prior results do not guarantee a similar outcome.

Rigrodsky & Long, P.A.
Brian Long
Shaye Fuchs
888-969-4242
516-683-3516
Fax: 302-654-7530
info@rl-legal.com
http://www.rigrodskylong.com

Products
  • Globe Unlimited

    Digital all access pass across devices. subscribe

  • The Globe and Mail Newspaper

    Newspaper delivered to your doorstep. subscribe

  • Globe2Go

    The digital replica of our newspaper. subscribe

  • Globe eBooks

    A collection of articles by the Globe. subscribe

See all Globe Products

Advertise with us

GlobeLink.ca

Your number one partner for reaching Canada's Influential Achievers. learn more

The Globe at your Workplace
Our Company
Customer Service
Globe Recognition
Mobile Apps
NEWS APP
INVESTING APP
Other Sections